Splinter TA - Search Results

1

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Kok TC, Van der Gaast A, Dees J, Eykenboom WM, Van Overhagen H, Stoter G, Tilanus HW, Splinter TA. Kok TC, et al. Among authors: splinter ta. Br J Cancer. 1996 Sep;74(6):980-4. doi: 10.1038/bjc.1996.469. Br J Cancer. 1996. PMID: 8826870 Free PMC article. Clinical Trial.

2

Teniposide (VM-26) in ovarian cancer: a review.

van der Gaast A, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Semin Oncol. 1992 Apr;19(2 Suppl 6):95-7. Semin Oncol. 1992. PMID: 1411643 Review.

3

What is the optimal dose and duration of treatment with etoposide? I. Maximum tolerated duration of daily treatment with 50, 75, and 100 mg of oral etoposide.

Splinter TA, van der Gaast A, Kok TC. Splinter TA, et al. Semin Oncol. 1992 Dec;19(6 Suppl 14):1-7. Semin Oncol. 1992. PMID: 1488650

4

What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days.

van der Gaast A, Vlastuin M, Kok TC, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Semin Oncol. 1992 Dec;19(6 Suppl 14):8-12. Semin Oncol. 1992. PMID: 1488657

5

Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas.

Van Der Gaast A, Verwey J, Prins E, Splinter TA. Van Der Gaast A, et al. Among authors: splinter ta. Cancer. 1990 Feb 1;65(3):422-4. doi: 10.1002/1097-0142(19900201)65:3<422::aid-cncr2820650308>3.0.co;2-y. Cancer. 1990. PMID: 1688727

6

Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.

Kok TC, van der Gaast A, Splinter TA, Tilanus HW. Kok TC, et al. Among authors: splinter ta. Eur J Cancer. 1991;27(9):1112-4. doi: 10.1016/0277-5379(91)90305-w. Eur J Cancer. 1991. PMID: 1835618

7

Growing teratoma syndrome successfully treated with lymphoblastoid interferon.

van der Gaast A, Kok TC, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Eur Urol. 1991;19(3):257-8. doi: 10.1159/000473633. Eur Urol. 1991. PMID: 1855534

8

Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma.

Bac DJ, Kok TC, van der Gaast A, Splinter TA. Bac DJ, et al. Among authors: splinter ta. J Cancer Res Clin Oncol. 1991;117(3):263-5. doi: 10.1007/BF01625436. J Cancer Res Clin Oncol. 1991. PMID: 2033095

9

Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study.

Splinter TA, Obertop H, Kok TC, Jeekel J. Splinter TA, et al. J Cancer Res Clin Oncol. 1989;115(2):200-2. doi: 10.1007/BF00397924. J Cancer Res Clin Oncol. 1989. PMID: 2715169

10

Etoposide and cisplatin in advanced esophageal cancer. A preliminary report.

Kok TC, Splinter TA, Verweij J. Kok TC, et al. Among authors: splinter ta. Acta Oncol. 1988;27(6b):807-9. doi: 10.3109/02841868809094362. Acta Oncol. 1988. PMID: 3233166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters